🇺🇸 FDA
Patent

US 11565107

Tolerable and minimally invasive skin electroporation device

granted A61KA61K2039/53A61K2039/54

Quick answer

US patent 11565107 (Tolerable and minimally invasive skin electroporation device) held by Inovio Pharmaceuticals, Inc. expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K39/12, A61K39/145